Local consolidative therapy extends survival in metastatic NSCLC with oligoresidual disease following first-line immunotherapy, irrespective of PD-L1 expression

W Wangti Xie M Maohui Yan F Fang Wen Y Yu Wu X Xiaosan Cheng J Jianbing Hu J Jia Xiao (Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Hospital Affiliated with Jinan University) P Pan Luo (Beijing Frontier Research Center on Clean Energy) Y Yuqi Su L Ling Ni (Research Institute of General Surgery and Department of Gastroenterology, Jinling Hospital, Medical School of Nanjing University) R Rong Shan X Xiang Yao (Department of Chemistry and Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University, Shanghai 200433, China) X Xianggan Huang T Tunqian Liu Y Yuan Liu J Jie Weng